Edit | |
---|---|
Product Name | Santacruzamate A |
Description | Santacruzamate A is a small molecule which can act as an Ultrapotent HDAC2 inhibitor. It is provided as a powder. This product acts on the following target types: Protein deacetylase. This product acts on the following biochemical pathways: Chromatin, Apoptosis inducer, Posttranslational modification. This product may be of interest in the following research areas and diseases: Cellular stress, Cell death, Epigenetics, Neuroscience, Neurodegeneration, Cancer. This product may act as a Coronavirus inhibitor: HDAC2 interacts with SARS-CoV-2 Nsp5. Please note that our chemical products are for scientific research use only and are not for medical or veterinary use. This product can only be dispatched to a scientific business or laboratory address. MW: 278.35 g/mol |
Size | 5 mg, 25 mg |
Concentration | n/a |
Applications | n/a |
Other Names | Santacruzamate A, N-[4-Oxo-4-[(2-phenylethyl)amino]butyl]-carbamic acid, ethyl ester, 1477949-42-0 |
Gene, Accession, CAS # | CAS: 1477949-42-0 |
Catalog # | abx282919 |
Price | please inquire |
Order / More Info | Santacruzamate A from ABBEXA LTD |
Product Specific References | n/a |
U.S. Office
118 Eldridge Rd, Suite C,
Sugar Land, TX 77478 USA
Telephone: +1 832 327 7413
Netherlands Office
Abbexa BV
Wattstraat 54 2723 RD,
Zoetermeer,Netherlands
Telephone: +44 (0) 1223 755950